Trials / Completed
CompletedNCT00097552
A Study to Evaluate Subjects With Turner Syndrome Treated With Growth Hormone
Characterization of Subjects With Turner Syndrome Treated With Growth Hormone in the National Cooperative Growth Study (NCGS)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,696 (actual)
- Sponsor
- Genentech, Inc. · Industry
- Sex
- Female
- Age
- 17 Years
- Healthy volunteers
- Not accepted
Summary
This study is a multicenter, open-label, observational, postmarketing surveillance study of Genentech growth hormone (GH) products in the treatment of girls with Turner syndrome in the United States and Canada.
Conditions
Timeline
- Start date
- 1997-05-01
- Primary completion
- 2010-07-01
- Completion
- 2010-07-01
- First posted
- 2004-11-25
- Last updated
- 2012-11-14
Source: ClinicalTrials.gov record NCT00097552. Inclusion in this directory is not an endorsement.